نتائج البحث - "Wataru Fukuokaya"

1

Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer

المؤلفون: Hirotaka Suzuki, Takashi Otsuka, Takayuki Sano, Keigo Sakanaka, Tatsuya Shimomura, Keiichiro Miyajima, Takafumi Yanagisawa, Kenichi Hata, Wataru Fukuokaya, Yuki Enei, Shin Egawa, Akihiro Matsukawa, Yuya Iwamoto, Jun Miki, Shunsuke Tsuzuki, Hajime Onuma, Keiichiro Mori, Takahiro Kimura, Koki Obayashi

المصدر: The Prostate. 82:3-12

مصطلحات موضوعية: Male, Oncology, Comparative Effectiveness Research, medicine.medical_specialty, Bicalutamide, medicine.drug_class, Prednisolone, Urology, Abiraterone Acetate, Antiandrogen, Risk Assessment, Metastasis, Tosyl Compounds, Androgen deprivation therapy, chemistry.chemical_compound, Prostate cancer, Japan, Liver Function Tests, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Nitriles, medicine, Humans, Anilides, Nonsteroidal Anti-Androgens, Neoplasm Staging, Retrospective Studies, business.industry, Proportional hazards model, Liver Neoplasms, Abiraterone acetate, Prostatic Neoplasms, Androgen Antagonists, Middle Aged, Prognosis, medicine.disease, Prostatic Neoplasms, Castration-Resistant, chemistry, Neoplasm Grading, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63aa9026f7a3bd9a7a293f934be99cfTest
https://doi.org/10.1002/pros.24243Test

2

Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer

المصدر: Japanese Journal of Clinical Oncology. 51:1665-1671

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Lactate dehydrogenase, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Retrospective Studies, L-Lactate Dehydrogenase, Proportional hazards model, business.industry, Hazard ratio, Prostatic Neoplasms, Androgen Antagonists, Retrospective cohort study, General Medicine, Alkaline Phosphatase, Prognosis, medicine.disease, Hormones, Androgen receptor, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Alkaline phosphatase, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca64e70eea9e33e609c75690030a9f6Test
https://doi.org/10.1093/jjco/hyab115Test

3

Risk stratification for the prediction of overall survival could assist treatment decision‐making at diagnosis of castration‐resistant prostate cancer: a multicentre collaborative study in Japan

المصدر: BJU International. 127:212-221

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0affbe7dff12027c8a7f5b5bb7bdb4b8Test
https://doi.org/10.1111/bju.15187Test

4

Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer

المؤلفون: Wataru Fukuokaya, Kojiro Tashiro, Yusuke Koike, Hiroshi Sasaki, Shunsuke Tsuzuki, Shoji Kimura, Kenta Miki, Fumihiko Urabe, Shin Egawa, Takahiro Kimura

المصدر: International Journal of Clinical Oncology. 25:1695-1703

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Erythrocytes, Docetaxel, Lower risk, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Nitriles, Phenylthiohydantoin, Biomarkers, Tumor, medicine, Humans, Enzalutamide, Mean platelet volume, Aged, Proportional Hazards Models, Retrospective Studies, Platelet Count, business.industry, Proportional hazards model, Hazard ratio, Abiraterone acetate, Hematology, General Medicine, Prostate-Specific Antigen, Prognosis, medicine.disease, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, 030104 developmental biology, chemistry, Receptors, Androgen, 030220 oncology & carcinogenesis, Benzamides, Androstenes, Surgery, business, Mean Platelet Volume, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed9d67e7803516862cfbcf11201172eTest
https://doi.org/10.1007/s10147-020-01712-yTest

5

Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer

المؤلفون: Kenta Miki, Keigo Sakanaka, Takahiro Kimura, Keiichiro Mori, Gaku Kurokawa, Takafumi Yanagisawa, Katsuhisa Endo, Jun Miki, Wataru Fukuokaya, Hiroshi Sasaki, Tatsuya Shimomura, Takashi Hatano, Shin Egawa, Kosuke Iwatani

المصدر: International Journal of Clinical Oncology. 25:479-485

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Kaplan-Meier Estimate, urologic and male genital diseases, Metastasis, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Castration Resistance, Internal medicine, Nitriles, Phenylthiohydantoin, Humans, Medicine, Enzalutamide, Prospective cohort study, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Apalutamide, Androgen Antagonists, Retrospective cohort study, Hematology, General Medicine, Middle Aged, Alkaline Phosphatase, medicine.disease, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, 030104 developmental biology, Thiohydantoins, chemistry, 030220 oncology & carcinogenesis, Benzamides, Surgery, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931c742adb327347b4b19ad4512223c6Test
https://doi.org/10.1007/s10147-019-01541-8Test

6

Differences in sex hormone recovery profile after cessation of 12-week gonadotropin-releasing hormone antagonist versus agonist therapy

المؤلفون: Kenta Miki, Takahiro Kimura, Hiroyuki Takahashi, Shun Sato, Hiroshi Sasaki, Kojiro Tashiro, Fumihiko Urabe, Wataru Fukuokaya, Keiichiro Mori, Shin Egawa, Manabu Aoki

المصدر: AndrologyREFERENCES. 10(2)

مصطلحات موضوعية: Male, Time Factors, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Brachytherapy, Androgen deprivation therapy, Gonadotropin-Releasing Hormone, Iodine Radioisotopes, chemistry.chemical_compound, Endocrinology, Leuprorelin, Testosterone, Prospective Studies, Neoadjuvant therapy, Prostate, Organ Size, Middle Aged, Neoadjuvant Therapy, Treatment Outcome, Goserelin, Luteinizing hormone, Oligopeptides, hormones, hormone substitutes, and hormone antagonists, medicine.drug, endocrine system, medicine.medical_specialty, Antineoplastic Agents, Hormonal, medicine.drug_class, Urology, Gonadotropin-releasing hormone antagonist, Gonadotropin-releasing hormone agonist, Internal medicine, medicine, Humans, Degarelix, Aged, Neoplasm Staging, business.industry, Prostatic Neoplasms, Androgen Antagonists, Prostate-Specific Antigen, Reproductive Medicine, chemistry, Withholding Treatment, Quality of Life, Leuprolide, business, Orchiectomy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e120066514dc07e789770cd00b7268Test
https://pubmed.ncbi.nlm.nih.gov/34510814Test

7

Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer

المصدر: Cancers
Volume 13
Issue 3
Cancers, Vol 13, Iss 526, p 526 (2021)

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Multivariate analysis, medicine.drug_class, Urology, urologic and male genital diseases, lcsh:RC254-282, Article, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, mental disorders, medicine, Enzalutamide, castration-resistant prostate cancer, prostate-specific antigen, 030212 general & internal medicine, enzalutamide, business.industry, Abiraterone acetate, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Androgen, medicine.disease, Prostate-specific antigen, Abiraterone, Oncology, chemistry, abiraterone acetate, 030220 oncology & carcinogenesis, androgen signaling inhibitors, early PSA, PSA decline, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f295a73b38c4acb5f3572f08f67e11Test
https://pubmed.ncbi.nlm.nih.gov/33573172Test

8

Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis-Targeted Agents

المؤلفون: Mariko Honda, Hiroshi Sasaki, Kenta Miki, Shin Egawa, Keiichiro Mori, Takahiro Kimura, Wataru Fukuokaya, Tatsuya Shimomura, Hajime Onuma, Hiroyuki Inaba

المصدر: Clinical genitourinary cancer. 17(3)

مصطلحات موضوعية: Oncology, Erythrocyte Indices, Male, medicine.medical_specialty, Urology, 030232 urology & nephrology, Abiraterone Acetate, urologic and male genital diseases, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Interquartile range, Adrenal Cortex Hormones, Internal medicine, Nitriles, Phenylthiohydantoin, Medicine, Enzalutamide, Humans, Molecular Targeted Therapy, Neoplasm Metastasis, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Abiraterone acetate, Red blood cell distribution width, Prostate-Specific Antigen, medicine.disease, Prognosis, Survival Analysis, Androgen receptor, Prostate-specific antigen, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, Docetaxel, 030220 oncology & carcinogenesis, Benzamides, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6b6b99232f0348fecf98f021ffb5c3Test
https://pubmed.ncbi.nlm.nih.gov/31080022Test

9

Prognostic significance of lactate dehydrogenase-5 expression in patients with prostate cancer treated with androgen deprivation therapy and androgen receptor axis-targeted agents

المؤلفون: Takahiro Kimura, Mariko Honda, Hiroyuki Takahashi, Mori Keiichiro, Shin Egawa, Kosuke Iwatani, Wataru Fukuokaya, Shun Sato, Hiroyuki Inaba

المصدر: Journal of Clinical Oncology. 37:300-300

مصطلحات موضوعية: Cancer Research, Tumor hypoxia, business.industry, medicine.disease, Androgen deprivation therapy, Androgen receptor, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Oncology, chemistry, 030220 oncology & carcinogenesis, Lactate dehydrogenase, medicine, Cancer research, In patient, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f9fbd50cd256085f2e6c3eff5c150965Test
https://doi.org/10.1200/jco.2019.37.7_suppl.300Test

تنقيح النتائج